Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin added to radiotherapy for non-small cell lung cancer
NL-OMON39504Phase 2Active, not recruiting
- Sponsor
- Maastro Clinic
- Start
- Dec 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of nitroglycerin in non-small cell lung cancer (NSCLC), sponsored by Maastro Clinic. Primary endpoint: 2-year overall survival. Started Dec 2011; status: active, not recruiting.
02
Drugs
nitroglycerin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NL-OMON39504.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39504.